Zhu Susi, Zhang Xu, Liu Waner, Zhou Zhe, Xiong Siyu, Li Jie, Chen Xiang, Peng Cong
Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
Cancer Commun (Lond). 2025 Jun 19. doi: 10.1002/cac2.70044.
Ubiquitination, a key post-translational modification, plays an essential role in tumor biology by regulating fundamental cellular processes, such as metabolism and cell death. Additionally, it interacts with other post-translational modifications, which are closely linked to tumorigenesis, tumor progression, the tumor microenvironment, and the response to therapeutic interventions. Recent advancements in understanding the ubiquitination mechanisms have led to significant breakthroughs, offering novel perspectives and strategies for diagnosing and treating tumors. Here, we provided an overview of how ubiquitination influences tumor biology, focusing on its roles in immune regulation, metabolism, and its interactions with other modifications. We also summarized the clinical potential of targeting E3 ubiquitin ligases and deubiquitinases as therapeutic strategies in cancer treatment.
泛素化是一种关键的翻译后修饰,通过调节新陈代谢和细胞死亡等基本细胞过程,在肿瘤生物学中发挥着重要作用。此外,它还与其他翻译后修饰相互作用,这些修饰与肿瘤发生、肿瘤进展、肿瘤微环境以及对治疗干预的反应密切相关。在理解泛素化机制方面的最新进展取得了重大突破,为肿瘤的诊断和治疗提供了新的视角和策略。在此,我们概述了泛素化如何影响肿瘤生物学,重点关注其在免疫调节、新陈代谢中的作用以及与其他修饰的相互作用。我们还总结了将E3泛素连接酶和去泛素化酶作为癌症治疗中的治疗策略的临床潜力。